Resmed (RMD) Receivables (2010 - 2026)

Resmed's Receivables history runs 17 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• Quarterly Receivables rose 9.01% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 9.01% YoY) and the FY2025 annual result came in at $990.7 million, up 13.16% from the prior year.
• Receivables was $1.0 billion for Q1 2026 at Resmed, roughly flat from $1.0 billion in the prior quarter.
• Across five years, Receivables topped out at $1.0 billion in Q4 2025 and bottomed at $534.2 million in Q1 2022.
• A 5-year average of $815.9 million and a median of $817.2 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables fell 3.77% — and 2023, when it surged 33.31%.
• Resmed's Receivables stood at $695.4 million in 2022, then climbed by 9.91% to $764.3 million in 2023, then grew by 18.66% to $907.0 million in 2024, then rose by 15.45% to $1.0 billion in 2025, then declined by 0.11% to $1.0 billion in 2026.
• Business Quant data shows RMD's Receivables at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $958.4 million in Q3 2025.